Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

cyclin D Inhibitors

Cyclin D inhibitors belong to a specific class of chemical compounds that have garnered significant interest in the field of biomedical research due to their potential in regulating cell cycle progression. The cell cycle is a highly orchestrated process that governs cell growth and division, ensuring the maintenance of tissue homeostasis and proper development. Key players in this regulatory process are cyclins, a family of proteins that bind to cyclin-dependent kinases (CDKs), resulting in the formation of active CDK-cyclin complexes. Among these, the cyclin D family plays a crucial role in the early stages of the cell cycle, where they activate CDK4 and CDK6.Cyclin D inhibitors act by specifically targeting and modulating the activity of CDK4 and CDK6, leading to the suppression of their catalytic function. This, in turn, impedes the progression of the cell cycle from the G1 phase to the S phase, halting cell division. The inhibition of cyclin D complexes serves as a pivotal mechanism to maintain cell cycle control and prevent uncontrolled proliferation. The chemical structures of cyclin D inhibitors can vary widely, and researchers have developed a diverse array of compounds to target CDK4 and CDK6 effectively. These inhibitors function by competitively binding to the ATP-binding site within the CDKs, blocking the ATP molecules from binding and preventing the activation of the CDK-cyclin complexes. By doing so, cyclin D inhibitors play a significant role in regulating the delicate balance of cell division, ensuring proper growth, and preventing aberrant proliferation.Moreover, cyclin D inhibitors are valuable tools in cell biology research to investigate cell cycle pathways and signaling cascades. Researchers utilize these compounds to explore the functions of cyclin D-CDK complexes in different cellular processes, including development, tissue regeneration, and cell differentiation. Understanding the specific mechanisms of action of cyclin D inhibitors can lead to novel insights into cell cycle regulation and potential avenues characterized by abnormal cell growth. Overall, cyclin D inhibitors represent a fascinating class of chemical compounds with significant implications for cell biology research. Their ability to modulate key cell cycle regulators offers exciting possibilities for advancing our understanding of cellular dynamics.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a versatile compound that interacts with cyclin D, exhibiting a unique ability to disrupt its binding with cyclin-dependent kinases. This disruption alters the phosphorylation state of target proteins, influencing cell cycle progression. The compound's intricate molecular structure allows for specific hydrogen bonding and hydrophobic interactions, which modulate the stability of the cyclin D-CDK complex, ultimately affecting cellular signaling cascades and regulatory mechanisms.

Hygrolidin

83329-73-1sc-391768
sc-391768A
sc-391768B
sc-391768C
1 mg
5 mg
10 mg
25 mg
$332.00
$1300.00
$1900.00
$3749.00
(0)

Hygrolidin is a distinctive compound that engages with cyclin D through selective binding, influencing its conformation and stability. This interaction alters the dynamics of cyclin-dependent kinase complexes, impacting downstream signaling pathways. The compound's unique functional groups facilitate specific electrostatic interactions and steric effects, enhancing its ability to modulate protein-protein interactions. Its kinetic profile reveals a nuanced approach to regulating cellular processes, showcasing its role in cellular homeostasis.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

PD 0332991 is a small molecule inhibitor that specifically targets cyclin-dependent kinases 4 and 6 (CDK4/6), which are critical regulators of the cell cycle.

Abemaciclib

1231929-97-7sc-507342
10 mg
$110.00
(0)

Abemaciclib is a CDK4/6 inhibitor that can be used as a monotherapy or in combination with other agents.

N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine Methanesulfonate

1231930-82-7sc-496536
2.5 mg
$398.00
(0)

Also known as Abemaciclib-derivative, LY2835219 is a potent and selective inhibitor of CDK4/6 and has shown potential in research studies for various cells and tissues. This chemical is also known as Abemaciclib methanesulfonate

Aurora Kinase/Cdk Inhibitor

443797-96-4sc-203829
5 mg
$440.00
(0)

JNJ-7706621 is an investigational CDK4/6 inhibitor that has shown activity in research studies.

P276-00

920113-03-7sc-477932
1 mg
$380.00
(0)

P276-00 is a novel CDK inhibitor that targets multiple cyclin-dependent kinases, including CDK4 and CDK6.

SNS-032

345627-80-7sc-364621
sc-364621A
5 mg
10 mg
$169.00
$262.00
(1)

SNS-032 is a selective inhibitor of CDK2, CDK7, and CDK9, but it also exhibits activity against CDK4/6, showing potential as a cyclin D inhibitor.